Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.08.2019 | Case report

Alendronic acid/denosumab

Atypical femoral fractures: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a case series, two women aged 78 years and 60 years were described, who developed atypical femoral fractures (AFF) during treatment with alendronic acid (1 patient) or denosumab and alendronic acid (1 patient) [dosages and routes not stated]. …
Literatur
Zurück zum Zitat Choy KH, et al. Atypical femoral fractures in association with antiresorptive therapy: A case series. Osteoporosis International 30 (Suppl. 1): S72-S73 (plus poster) abstr. P048, May 2019. Available from: URL: http://doi.org/10.1007/s00198-018-04815-5 [abstract] - Australia Choy KH, et al. Atypical femoral fractures in association with antiresorptive therapy: A case series. Osteoporosis International 30 (Suppl. 1): S72-S73 (plus poster) abstr. P048, May 2019. Available from: URL: http://​doi.​org/​10.​1007/​s00198-018-04815-5 [abstract] - Australia
Metadaten
Titel
Alendronic acid/denosumab
Atypical femoral fractures: 2 case reports
Publikationsdatum
01.08.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-65777-6

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Trastuzumab

Case report

Apremilast

Case report

Rituximab

Case report

Oxaliplatin

Case report

Brimonidine